Allied Blenders and Distillers Limited — Q2 FY26 earnings call

Call held 6 Nov 2025

Management summary

Allied Blenders delivered a strong Q2 FY26, marked by double-digit growth in revenue, EBITDA, and PAT, driven by premiumization and international expansion. The company successfully commissioned its PET bottle facility, enhancing margins and operational control. While Mass Premium faced headwinds from regulatory changes, the Prestige & Above segment continued its robust growth, and the company remains optimistic about market normalization and future growth initiatives.

Highlights

  • Strong financial performance with 14.4% YoY revenue growth to ₹995 crores.

  • Significant profitability improvement: EBITDA up 23.6% to ₹130 crores (13.1% margin) and PAT up 32.3% to ₹63 crores.

  • Robust volume growth of 8.4% YoY to 9 million cases, coupled with a 3.8% increase in realization per case.

  • Prestige & Above category showed strong momentum with 28.8% YoY volume growth, increasing its salience to 47.1%.

  • Successful commissioning of the PET bottle manufacturing facility, expected to add ₹30 crores+ to gross margins and improve supply chain efficiency.

  • International expansion is impressive, reaching 30 countries from 14 in 18 months, with a target of 35 countries by Q4 FY26 and 1 million cases in Africa by FY28.

Concerns

  • Mass Premium category witnessed 5% degrowth versus Q2 FY25, primarily due to regulatory intervention in southern states and the Maharashtra-made liquor policy.

  • Telangana market faced temporary pipeline impact and overdues, though expected to normalize by Q3 FY26.

  • Net debt increased by ₹127 crores to ₹893 crores as of September 30, 2025, primarily due to capex investments.

Key financials

2 periods

Headline

  • Consolidated Income from Operations
    ₹995 Cr
    YoY +14.4%
  • EBITDA
    ₹130 Cr
    YoY +23.6%
  • EBITDA Margin
    13.1%
  • PAT
    ₹63 Cr
    YoY +32.3%
  • Volume Sales
    9 million cases
    YoY +8.4%
  • Realization per Case Growth
    3.8%
  • Net Debt
    ₹893 Cr

H1 FY26

  • Operating Cash Flow
    ₹147 Cr
  • Average Cost of Borrowing
    8.2%

What they filed

Q1 FY27: revenue up 5.5%, net profit up 11.5% against the same quarter last year.

₹ Cr · quarterly
Line itemQ2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Revenue868 974 921 919 984 +13%985 +1%993 +8%970 +6%
EBITDA104 117 136 115 132 +27%147 +26%181 +33%134 +17%
Net profit48 58 81 61 72 +50%78 +34%57 −30%68 +11%
How to read this

₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.

Segment breakdown

  • Mass Premium Category
    4.3% Volume Growth (Q2 vs Q1 FY26)-5% Volume Degrowth (vs Q2 FY25)
  • Prestige & Above Category
    8.3% Volume Growth (Q2 vs Q1 FY26)28.8% Volume Growth (YoY)47.1% Salience39.7% Salience (Q2 FY25)

Capital allocation

high confidence
  • Capex ₹527 Cr
    • PET bottle manufacturing facility in Rangapur, Telangana ₹115 Cr
    • Single malt distillery at Rangapur, Telangana
    • ENA distillation capacity expansion of Aurangabad
    Let me give you an update on our capex program. In September 2025, we also successfully commissioned our EBITDA-accretive PET bottle manufacturing facility in Rangapur, Telangana. This facility with a capital investment of approximately Rs. 115 crores. The facility is set to produce over 600 million PET bottles annually. Our other capex project, namely the single malt distillery at Rangapur, Telangana and ENA distillation capacity expansion of Aurangabad, Maharashtra are on track and are expected to be operational in Q4 FY '26 and Q4 FY '27, respectively. Okay. So if you recall in the earlier call, I had outlined roughly 25% of this Rs. 527 crores was invested last financial year. 60% of this Rs. 527 crores will be invested in this financial year and the balance 15% will be invested in the next financial year. So the capex investment is broken 25% last year, 60% this year and 15% next year.
  • Debt Net ₹893 Cr Cost 8.2%
    • Rate reset Average cost of borrowing reduced by 140 basis points to 8.2% in H1 FY26 from 9.6% in H1 FY25.
    Our net debt position as on 30th September 2025 was Rs. 893 crores versus Rs. 766 crores on 31st March 2025. The increase in net debt of Rs. 127 crores is primarily on account of our capex, which I have already explained. It should also be noticed that the average cost of borrowing has reduced by 140 basis points to 8.2% in H1 FY '26 versus 9.6% in H1 FY '25 at the backdrop of two credit rating upgrades first one in October '25 and within nine months in July '26, driven by strong financial performance.
  • Liquidity Liquidity disclosed Operating cash flows of INR147 crores were generated in H1 FY '26 due to high profitability and working capital discipline.
    Operating cash flows of INR147 crores were generated in H1 FY '26 due to high profitability and working capital discipline.

Guidance & targets

International Footprint

  • Number of countries International Footprint · Q4 FY26 · High confidence 35
    By Q4 FY '26, ABD targets to increase its international footprint to reach 35 countries.

    — Alok Gupta, Managing Director

International Volume

  • Africa market volume International Volume · FY28 · High confidence 1 million cases
    The company remains committed to maintaining its market share in the GCC region while continuing to expand its distribution into Africa with a goal to reach 1 million cases by FY '28.

    — Alok Gupta, Managing Director

Segment Salience

  • P&A segment contribution Segment Salience · FY28 · Medium confidence 50%
    Also I think that we have the guidance for the P&A negative 50% by the end of FY '28. But we are at already I think 48% P&A contribution? So would you like to revise some guidance for FY '28 for P&A category, sorry? Again the guidance for the P&A, 50% by 2028. We are at 47% a you rightly pointed out. I think if there's a need to revise this guidance, we will certainly do so, by end of this financial year. So allow us to come back to us on new guidance.

    — Alok Gupta, Managing Director

Capex

  • Single malt distillery operational Capex · Q4 FY26 · High confidence Operational
    Our other capex project, namely the single malt distillery at Rangapur, Telangana and ENA distillation capacity expansion of Aurangabad, Maharashtra are on track and are expected to be operational in Q4 FY '26 and Q4 FY '27, respectively.

    — Alok Gupta, Managing Director

  • ENA distillation capacity operational Capex · Q4 FY26 and Q4 FY27 · High confidence Operational

    — Alok Gupta, Managing Director

Brand Performance

  • ABDM Maestro revenue run rate Brand Performance · Current · High confidence ₹40 crores
    The good news is that ABD Maestro is currently running on its revenue run rate is now about Rs. 40 odd crores, right? And we expect this to pretty much grow at a very fast pace quarter-on-quarter basis.

    — Alok Gupta, Managing Director

A&P Spend

  • A&P as % of P&A NSV A&P Spend · Current · High confidence 4.5-5%
    So the A&P spend, the demand in the Mass Premium segment is pretty low. So when we look at our A&P spend, it is roughly 4.5%, 5% of the P&A NSV.

    — Alok Gupta, Managing Director

  • Increase in A&P investment A&P Spend · Next 2-3 years · High confidence 75-100 bps YoY
    The way we are looking at is to increase our A&P investment between 75 basis to 100 basis points year-on-year for the next two or three years.

    — Alok Gupta, Managing Director

Regulatory

  • UK FTA import duty reduction Regulatory · Q1-Q2 next financial year · Medium confidence Expected
    I stand at this point of time we believe that this could be around quarter one to quarter two next financial year.

    — Alok Gupta, Managing Director

What to watch in Q3 FY26

Telangana market normalization

Q3 FY26
Current Impacted by licensing changes, pipeline correction underway
Target Business back to usual, pipeline correction complete

Why it matters

Normalization of this key market is crucial for Mass Premium volume recovery and overall sales.

And from 1st December, this will be business back as usual. And the pipeline correction that has happened, we see significant part of the pipeline correction to correct itself in the month of December itself. So we are gearing up to meet that demand. Mostly, it will normalize in Q3. That is right.

Risks & concerns

  • Regulatory intervention in southern states

    medium

    Caused 5% degrowth in Mass Premium category in Q2 FY26 vs Q2 FY25, with short-term pipeline impact.

    Management acknowledged

  • Maharashtra-made liquor policy (MML)

    medium

    Impacted IMFL volumes by about 20% and overall Alcobev market; management is engaging with policymakers but needs more time to assess.

    Management acknowledged

  • Telangana overdues

    medium

    Outstanding dues of ~₹700 crores (₹250-300 crores current, rest overdue), though ₹100 crores received in October 2025 and continuous reduction is expected.

    Management acknowledged

  • State-level regulatory changes and rise of local brands

    low

    Identified as a potential challenge in certain states, though regulatory reforms in other states like Andhra Pradesh are positive.

    Management acknowledged

Q&A highlights

6 direct
Impact of PET bottle manufacturing facility on gross margins and economies of scale Direct
this investment will add roughly Rs. 30 crores plus to our gross margins, translating to about 75 basis points, let's say, on current year volume. So that's the impact on our gross margin and absolute EBITDA in terms of the contribution that this unit will make. Secondly, on economies of scale, we do not have any disadvantage on economies of scale because the PET manufacturing is not centralized unlike the glass bottle manufacturing. PET manufacturing is fairly decentralized. So we have enough scale because we are producing 600 million bottles at this facility.

Clarifies the direct financial benefit (margin improvement) and addresses concerns about scale disadvantage for in-house PET production.

Asked by Abneesh Roy

Telangana market normalization and overdues resolution Partial
No. This is not just as far as Telangana is concerned, on back of the licenses because the retailers are pretty much buying what is getting sold. So this has impacted all segments, not just Mass Premium. Now the good news is that the lottery has been concluded. The new owners have been identified. And from 1st December, this will be business back as usual. And the pipeline correction that has happened, we see significant part of the pipeline correction to correct itself in the month of December itself. So we are gearing up to meet that demand. Mostly, it will normalize in Q3. That is right.

Provides a clear timeline for market normalization in Telangana (Q3 FY26) and confirms receipt of some overdue payments, indicating progress on a key regional challenge.

Asked by Nitin

Growth drivers for Super-Premium/Luxury segment and Indian brands Direct
First is that Indian consumers are now happy consuming, serving and gifting Indian brands. And that is the trend that you will see across the entire F&B and many other consumer categories. And therefore, consumers are giving Indian brands as much a chance that they will give to an international brand. So that one barrier is removed. There is, in fact, a positive bias for Indian brands. So consumers are happy trying Indian brands. The second thing is that launching a brand in the Luxury segment is required, but it also needs continuous flavour offerings to be made to the consumer.

Highlights the strategic shift in consumer preference towards Indian brands and the importance of continuous product innovation for success in the premium segments.

Asked by Abneesh Roy

Concentration of ICONIQ White in P&A category and diversification strategy Direct
If you look at the industry construct, the industry is about 400-odd million cases, of which 160 million is what we call as the P&A or the Prestige price point. Of this 120 million cases is whisky and about 40 million cases is brandy and vodka. The way we are architecting our portfolio strategy is with SRB7, ICONIQ and OC Blue, continue to get market shares from the 120 million case whisky Prestige market and introduce brand in the Prestige brandy and the Prestige vodka segment.

Explains the broader portfolio strategy beyond ICONIQ White, aiming for market share across whisky, brandy, and vodka in the Prestige segment, indicating a diversification approach.

Asked by Ishaan

Single malt distillery brand identity and launch timeline Direct
So our master blender has visualized as to what kind of a single malt profile we would launch in 2029. That is when we are targeting our single malt to come out. And right from distillation to maturation to the kind of cask, the maturation will happen. I think that blueprint is already ready. So quite excited about bringing our single malt in 2029.

Provides a long-term vision and specific launch year (2029) for the single malt, emphasizing authenticity and a well-thought-out strategy for a premium product.

Asked by Yash Bajaj

ICONIQ White volume and distribution expansion Direct
It's just about 5 million cases, shade under 5 million cases. So as far as domestic markets are concerned, our national rollout got finished sometime November, December last year with opening up of Andhra and Delhi. So with that, we have finished or concluded the rollout domestically. International market, we are currently in about eight markets. We believe this brand has relevance across 25, 30 markets.

Quantifies ICONIQ White's H1 FY26 volume and outlines its domestic and international distribution status, indicating continued expansion potential.

Asked by Sanjay Manyal

Profitability initiatives for ICONIQ White (mono carton removal, market bottles) Direct
The markets where we have removed mono carton, there is no impact. I think numbers speak for themselves. We did about 5.7 million cases all of last year. We've already done 4.9 million cases in H1. So the brand continues to grow organically. I think what is really working well for the brand is what we would call in classical marketing term is word of mouth. On the mono carton removal, you will recall I said within 12 months of launch we removed. Our last market of launch for November and December last year. So it's really Andhra and Delhi. So by December, the entire exercise of mono carton removal will be concluded.

Confirms the successful and impact-free removal of mono cartons, contributing to profitability, and provides a timeline for its full implementation across all markets.

Asked by Kunal Shah

Funding of capex and dividend payout policy Partial
No. We will need to borrow the balance capex for this financial year. But the way we have planned our borrowing is to make sure that it is well within all the key ratios that we have internally agreed as and the growth must be driven within certain KPIs. So all the borrowing is keeping those KPIs in mind. But we'll have to do a bit of all. This question is for next year because this last year dividend has been paid out this year. So I think we'll address this question at the right time.

Management confirms borrowing for capex but assures adherence to financial ratios, while deferring specific dividend payout guidance to the next year.

Asked by Nitin

3 min read 7 chapters

Detailed narrative

Strong Q2 FY26 Financial Performance

Allied Blenders reported a robust Q2 FY26, with consolidated income from operations reaching ₹995 crores, marking a 14.4% year-on-year increase. EBITDA grew by 23.6% to ₹130 crores, improving the margin to 13.1%. Profit after tax (PAT) saw a significant jump of 32.3% to ₹63 crores. Volume sales increased by 8.4% to 9 million cases, complemented by a 3.8% rise in realization per case, indicating effective product mix and pricing strategies.

Premiumization and Brand Momentum

The company's premiumization strategy continues to yield results, with the Prestige & Above (P&A) segment demonstrating strong growth. P&A volumes grew 28.8% year-on-year, increasing its salience to 47.1% from 39.7% in Q2 FY25. ICONIQ White remains a standout performer, doubling its volume organically and expanding its international footprint to eight countries. Officer's Choice continues to lead the Mass Premium segment, maintaining over 40% gross margins and driving cash flow. The refreshed Sterling Reserve B7 campaign, 'So Smooth Must Be Magic,' is reversing degrowth trends in priority markets.

Strategic International Expansion

Allied Blenders' international expansion has been impressive, growing its reach from 14 to 30 countries within 18 months, with a target of 35 countries by Q4 FY26. The company aims to achieve 1 million cases in the Africa market by FY28 and expects international revenue to contribute 12-15% of total value. ICONIQ White is now available in eight countries, and luxury brands like Arthaus and Zoya Gin have debuted in UAE duty-free markets, showcasing a high-margin export model with less working capital.

Backward Integration and Capex Program

The company successfully commissioned its PET bottle manufacturing facility in Rangapur, Telangana, in September 2025, with a capital investment of ₹115 crores. This facility is expected to produce over 600 million PET bottles annually, adding over ₹30 crores to gross margins and enhancing supply chain efficiency. Other capex projects, including the single malt distillery at Rangapur and ENA distillation capacity expansion at Aurangabad, are on track for operationalization in Q4 FY26 and Q4 FY27, respectively. The overall capex program of ₹527 crores is phased, with 60% allocated for FY26 and 15% for FY27.

Financial Health and Capital Management

Operating cash flows of ₹147 crores were generated in H1 FY26, reflecting strong profitability and working capital discipline. Net debt increased by ₹127 crores to ₹893 crores as of September 30, 2025, primarily due to capex. The average cost of borrowing reduced by 140 basis points to 8.2% in H1 FY26 from 9.6% in H1 FY25, supported by two credit rating upgrades. The company maintains its leverage ratios within stated guidelines, even during the peak capex phase.

Market Dynamics and Regulatory Landscape

The Mass Premium segment experienced 5% degrowth in Q2 FY25 due to regulatory intervention in southern states, though normalization is expected by Q3 FY26. The Maharashtra-made liquor policy led to a 20% decline in IMFL volumes, with management awaiting further clarity. Telangana overdues saw some recovery, with ₹100 crores received in October 2025, and continuous reduction is anticipated. The industry benefits from stable raw material costs and regulatory reforms in states like Andhra Pradesh, supporting margin stability and volume recovery.

Luxury Portfolio and Future Outlook

ABDM's luxury portfolio, including Zoya Gin and Arthaus, is expanding its presence in addressable markets and travel retail. The company plans to launch three new brands in H2 FY26 to complete its portfolio. The A&P spend is currently 4.5-5% of P&A NSV, with plans to increase it by 75-100 basis points year-on-year for the next 2-3 years. Management is optimistic about a positive outlook for H2 FY26, driven by the festive season and continued focus on profitable growth and sustainability.

This is an AI-generated summary of a publicly available earnings call transcript.